Insider sale
RETINALGENIX TECHNOLOGIES INC.
$94.0K
10K shares
What this filing means
BAYERN STEVEN plans to sell 10K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $94.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2023ACC: 0001959173-23-003621
10K
Shares to sell
$94.0K
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Warrant Exercise
Cash/ check
3/26/2019
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2019 | Warrant Exercise Cash/ check | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
OTCPlanned
Units to sell
10K
Market value
$94.0K
8/31/2023
Total
Units
10K
Value
$94.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/31/2023 | 10K | $94.0K | OTC | Planned |
| Total | 10K | $94.0K | ||